AMPK Activation of PGC-1α/NRF-1-Dependent SELENOT Gene Transcription Promotes PACAP-Induced Neuroendocrine Cell Differentiation Through Tolerance to Oxidative Stress.


Journal

Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 13 07 2018
accepted: 13 09 2018
pubmed: 30 9 2018
medline: 30 8 2019
entrez: 30 9 2018
Statut: ppublish

Résumé

Several cues including pituitary adenylate cyclase-activating polypeptide (PACAP), which acts through cAMP stimulation, specify the conversion of sympathoadrenal (SA) precursors toward different cell phenotypes by promoting their survival and differentiation. Selenoprotein T (SELENOT) is a PACAP-stimulated ER oxidoreductase that exerts an essential antioxidant activity and whose up-regulation is associated with SA cell differentiation. In the present study, we investigated the transcriptional cascade elicited by PACAP/cAMP to trigger SELENOT gene transcription during the conversion of PC12 cells from SA progenitor-like cells toward a neuroendocrine phenotype. Unexpectedly, we found that PACAP/cAMP recruits the canonical pathway that regulates mitochondrial function in order to elicit SELENOT gene transcription and the consequent antioxidant response during PC12 cell differentiation. This cascade involves LKB1-mediated AMPK activation in order to stimulate SELENOT gene transcription through the PGC1-α/NRF-1 complex, thus allowing SELENOT to promote PACAP-stimulated neuroendocrine cell survival and differentiation. Our data reveal that a PACAP and cAMP-activated AMPK-PGC-1α/NRF-1 cascade is critical for the coupling of oxidative stress tolerance, via SELENOT gene expression, and mitochondrial biogenesis in order to achieve PC12 cell differentiation. The data further highlight the essential role of SELENOT in cell metabolism during differentiation.

Identifiants

pubmed: 30267375
doi: 10.1007/s12035-018-1352-x
pii: 10.1007/s12035-018-1352-x
doi:

Substances chimiques

Nuclear Respiratory Factor 1 0
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha 0
Pituitary Adenylate Cyclase-Activating Polypeptide 0
Ppargc1a protein, rat 0
Selenoproteins 0
AMP-Activated Protein Kinases EC 2.7.11.31

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4086-4101

Références

Proc Natl Acad Sci U S A. 1976 Jul;73(7):2424-8
pubmed: 1065897
Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5849-54
pubmed: 21436046
J Neurochem. 2012 Nov;123 Suppl 2:125-37
pubmed: 23050650
Trends Endocrinol Metab. 2012 Sep;23(9):459-66
pubmed: 22817841
J Biol Chem. 2013 May 24;288(21):14936-48
pubmed: 23564451
J Biol Chem. 2014 Apr 4;289(14):10126-39
pubmed: 24567337
FASEB J. 2008 Jun;22(6):1756-68
pubmed: 18198219
Acta Physiol (Oxf). 2008 Feb;192(2):309-24
pubmed: 18005393
J Biol Chem. 1994 Feb 25;269(8):6207-14
pubmed: 7907091
EMBO Rep. 2017 Nov;18(11):1935-1946
pubmed: 28928140
Endocrinology. 2013 Oct;154(10):3796-806
pubmed: 23913443
Peptides. 2002 Aug;23(8):1471-8
pubmed: 12182949
Biochem J. 2000 Feb 1;345 Pt 3:673-80
pubmed: 10642527
Cell Metab. 2014 Dec 2;20(6):939-52
pubmed: 25448702
Neurobiol Dis. 2014 Mar;63:1-11
pubmed: 24269733
Genes Dev. 1993 Dec;7(12A):2431-45
pubmed: 8253388
J Cell Mol Med. 2007 Mar-Apr;11(2):286-98
pubmed: 17488477
FASEB J. 2012 Aug;26(8):3199-211
pubmed: 22532442
J Biol Chem. 2007 Jan 5;282(1):194-9
pubmed: 17099248
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):461-6
pubmed: 11756684
J Neurochem. 2011 Aug;118(4):460-74
pubmed: 21623793
Biochem Biophys Res Commun. 2005 Aug 19;334(1):199-206
pubmed: 15992771
Mol Cell Biol. 1993 Jun;13(6):3641-9
pubmed: 8388540
Cell. 1999 Jul 9;98(1):115-24
pubmed: 10412986
Mol Cell. 2004 Nov 5;16(3):399-411
pubmed: 15525513
J Neurochem. 2014 Oct;131(1):21-32
pubmed: 24899316
Neuroscience. 1998 Jun;84(3):801-12
pubmed: 9579785
Regul Pept. 2006 Nov 15;137(1-2):89-94
pubmed: 16928405
Hum Mol Genet. 2016 Mar 15;25(6):1043-58
pubmed: 26681807
Am J Clin Nutr. 2011 Apr;93(4):884S-90
pubmed: 21289221
J Neurosci. 1997 Jan 1;17(1):83-90
pubmed: 8987738
Trends Endocrinol Metab. 2001 Oct;12(8):360-5
pubmed: 11551810
Annu Rev Neurosci. 1993;16:129-58
pubmed: 8460888
Cell Rep. 2017 Oct 3;21(1):1-9
pubmed: 28978464
Genes Dev. 2011 Sep 15;25(18):1895-908
pubmed: 21937710
Pharmacol Rev. 2009 Sep;61(3):283-357
pubmed: 19805477
Mol Cell Biochem. 2014 Feb;387(1-2):187-95
pubmed: 24242043
Dev Biol. 2006 Oct 15;298(2):335-43
pubmed: 16928368
Am J Clin Nutr. 2011 Apr;93(4):891S-6
pubmed: 21325438
J Mol Neurosci. 2010 Nov;42(3):397-403
pubmed: 20387010
Neurosci Lett. 2007 Jan 10;411(2):98-103
pubmed: 17110029
Gene. 2002 Mar 6;286(1):81-9
pubmed: 11943463
Free Radic Biol Med. 2018 Nov 1;127:145-152
pubmed: 29800653
Endocrinology. 2003 Jun;144(6):2368-79
pubmed: 12746297
DNA Cell Biol. 1997 Mar;16(3):323-33
pubmed: 9115641
Gene Regul Syst Bio. 2013 Nov 04;7:139-52
pubmed: 24250222
J Cell Biochem. 2006 Mar 1;97(4):673-83
pubmed: 16329141
Cell. 2001 Aug 24;106(4):499-509
pubmed: 11525735
J Biol Chem. 1992 Mar 15;267(8):5108-13
pubmed: 1312085
Pharmacol Ther. 2008 Sep;119(3):291-310
pubmed: 18606183
J Mol Neurosci. 2014 Nov;54(3):370-9
pubmed: 24907941
Invest Ophthalmol Vis Sci. 2011 Feb 22;52(2):1055-63
pubmed: 21051700
Cell Stem Cell. 2016 Mar 3;18(3):396-409
pubmed: 26748418
Annu Rev Neurosci. 1999;22:541-66
pubmed: 10202548
Antioxid Redox Signal. 2016 Apr 10;24(11):557-74
pubmed: 26866473
FEBS Lett. 2014 Aug 25;588(17):3008-14
pubmed: 24928446
Development. 1998 Nov;125(22):4369-78
pubmed: 9778497
Mol Neurobiol. 2016 Nov;53(9):5818-5832
pubmed: 26497036
Cell. 2006 Oct 20;127(2):397-408
pubmed: 17055439
Cell Metab. 2005 Jul;2(1):9-19
pubmed: 16054095
Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7217-22
pubmed: 17438283
Adv Enzyme Regul. 2006;46:113-40
pubmed: 16887173
Methods. 2003 Sep;31(1):67-75
pubmed: 12893175
Nat Genet. 1998 Mar;18(3):231-6
pubmed: 9500544
J Cell Sci. 2012 Nov 1;125(Pt 21):4963-71
pubmed: 23277535
J Neurochem. 2006 Aug;98(4):1229-41
pubmed: 16787409
Genes Dev. 1990 Jun;4(6):1023-34
pubmed: 2166701
Cell Metab. 2005 Jan;1(1):15-25
pubmed: 16054041
Dev Cell. 2009 Feb;16(2):256-70
pubmed: 19217427
J Neurochem. 2006 Jul;98(2):321-9
pubmed: 16805827
Am J Physiol Endocrinol Metab. 2001 Dec;281(6):E1340-6
pubmed: 11701451
Endocrinology. 2011 Nov;152(11):4322-35
pubmed: 21896670
Eur J Neurosci. 2003 Jan;17(1):71-82
pubmed: 12534970
J Mol Neurosci. 2008 Nov;36(1-3):61-72
pubmed: 18491044
Mol Cell Biol. 2001 Jan;21(2):644-54
pubmed: 11134350
Genes Dev. 2010 Nov 15;24(22):2517-30
pubmed: 21078818

Auteurs

Houssni Abid (H)

UNIROUEN, Inserm U1239, Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Rouen-Normandie University, 76821, Mont-Saint-Aignan, France.
Institute for Research and Innovation in Biomedicine, 76000, Rouen, France.

Dorthe Cartier (D)

UNIROUEN, Inserm U1239, Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Rouen-Normandie University, 76821, Mont-Saint-Aignan, France.
Institute for Research and Innovation in Biomedicine, 76000, Rouen, France.

Abdallah Hamieh (A)

UNIROUEN, Inserm U1239, Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Rouen-Normandie University, 76821, Mont-Saint-Aignan, France.
Institute for Research and Innovation in Biomedicine, 76000, Rouen, France.

Anne-Marie François-Bellan (AM)

CNRS UMR 7051, Neurophysiopathol Inst, Aix-Marseille University, 13015 Marseille, France.

Christine Bucharles (C)

UNIROUEN, Inserm U1239, Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Rouen-Normandie University, 76821, Mont-Saint-Aignan, France.
Institute for Research and Innovation in Biomedicine, 76000, Rouen, France.

Hugo Pothion (H)

UNIROUEN, Inserm U1239, Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Rouen-Normandie University, 76821, Mont-Saint-Aignan, France.
Institute for Research and Innovation in Biomedicine, 76000, Rouen, France.

Destiny-Love Manecka (DL)

UNIROUEN, Inserm U1239, Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Rouen-Normandie University, 76821, Mont-Saint-Aignan, France.
Institute for Research and Innovation in Biomedicine, 76000, Rouen, France.

Jérôme Leprince (J)

UNIROUEN, Inserm U1239, Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Rouen-Normandie University, 76821, Mont-Saint-Aignan, France.
Institute for Research and Innovation in Biomedicine, 76000, Rouen, France.

Sahil Adriouch (S)

Institute for Research and Innovation in Biomedicine, 76000, Rouen, France.
UNIROUEN, Inserm U1234, Pathophysiology and Biotherapy of Inflammatory and Autoimmune Diseases, Rouen-Normandie University, 76000, Rouen, France.

Olivier Boyer (O)

Institute for Research and Innovation in Biomedicine, 76000, Rouen, France.
UNIROUEN, Inserm U1234, Pathophysiology and Biotherapy of Inflammatory and Autoimmune Diseases, Rouen-Normandie University, 76000, Rouen, France.

Youssef Anouar (Y)

UNIROUEN, Inserm U1239, Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Rouen-Normandie University, 76821, Mont-Saint-Aignan, France.
Institute for Research and Innovation in Biomedicine, 76000, Rouen, France.

Isabelle Lihrmann (I)

UNIROUEN, Inserm U1239, Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Rouen-Normandie University, 76821, Mont-Saint-Aignan, France. isabelle.lihrmann@univ-rouen.fr.
Institute for Research and Innovation in Biomedicine, 76000, Rouen, France. isabelle.lihrmann@univ-rouen.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH